Regulation of NFATc1 in Osteoclast Differentiation

키워드

참고문헌 (67)

1. Suda T., "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families", Endocr Rev., 20, pp.345~357 (1999)
2. Teitelbaum SL., "Bone resorption by osteoclasts", Science., 289, pp.1504~1508 (2000)
3. Walsh MC., "Osteoimmunology: interplay between the immune system and bone metabolism", Annu Rev Immunol., 24, pp.33~63 (2006)
4. Boyle WJ., "Osteoclast differentiation and activation", Nature., 423, pp.337~342 (2003)
5. Wiktor-Jedrzejczak W., "Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op", op) mouse, 1990, pp.87, 4828~4832
6. Yoshida H., "The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene", Nature., 345, pp.442~444 (1990)
7. Kong YY., "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature., 397, pp.315~323 (1999)
8. Dougall WC., "RANK is essential for osteoclast and lymph node development", Genes Dev., 13, pp.2412~2424 (1999)
9. Takayanagi H., "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol., 7, pp.292~304 (2007)
10. Takayanagi H., "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell., 3, pp.889~901 (2002)
11. Matsumoto M., "Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1", J Biol Chem., 279, pp.45969~45979 (2004)
12. Kim K., "Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis", J Biol Chem., 280, pp.35209~35216 (2005)
13. Kim Y., "Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis", J Biol Chem., 280, pp.32905~32913 (2005)
14. Winslow MM., "Calcineurin", NFAT signaling in osteoblasts regulates bone mass, 2006, pp.10, 771~782
15. Aliprantis AO., "NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism", J Clin Invest., 118, pp.3775~3789 (2008)
16. Hogan PG., "Transcriptional regulation by calcium, calcineurin, and NFAT", Genes Dev., 17, pp.2205~2232 (2003)
17. Graef IA., "NFAT signaling in vertebrate development", Curr Opin Genet Dev., 11, pp.505~512 (2001)
18. Crabtree GR., "NFAT signaling: choreographing the social lives of cells", Cell, 109(Suppl), pp.S67~79 (2002)
19. Kiani A., "Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation", J Leukoc Biol., 76, pp.1057~1065 (2004)
20. López-Rodríguez C., "Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress", Immunity., 15, pp.47~58 (2001)
21. Horsley V., "NFAT: ubiquitous regulator of cell differentiation and adaptation", J Cell Biol., 156, pp.771~774 (2002)
22. Takayanagi H., "The role of NFAT in osteoclast formation", Ann N Y Acad Sci., 1116, pp.227~237 (2007)
23. Hodge MR., "Charles de la Brousse F, et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice", Immunity., 4, pp.397~405 (1996)
24. Xanthoudakis S., "An enhanced immune response in mice lacking the transcription factor NFAT1", Science., 272, pp.892~895 (1996)
25. Yoshida H., "The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production", Immunity., 8, pp.115~124 (1998)
26. Ranger AM., "Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc", Immunity., 8, pp.125~134 (1998)
27. Johnson RS., "Pleiotropic effects of a null mutation in the c-fos proto-oncogene", Cell., 71, pp.577~586 (1992)
28. Wang ZQ., "Bone and haematopoietic defects in mice lacking c-fos", Nature., 360, pp.741~745 (1992)
29. Matsuo K., "Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos", J Biol Chem., 279, pp.26475~26480 (2004)
30. Asagiri M., "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis", J Exp Med., 202, pp.1261~1269 (2005)
31. Anderson DM., "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature., 390, pp.175~179 (1997)
32. Ghosh S., "Missing pieces in the NF-kappaB puzzle", Cell., 109(Suppl), pp.S81~96 (2002)
33. Hayden MS., "Signaling to NF-kappaB", Genes Dev., 18, pp.2195~2224 (2004)
34. Novack DV., "The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis", J Exp Med., 198, pp.771~781 (2003)
35. Ruocco MG., "IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss", J Exp Med., 201, pp.1677~1687 (2005)
36. Franzoso G., "Requirement for NF-kappaB in osteoclast and B-cell development", Genes Dev., 11, pp.3482~3496 (1997)
37. Iotsova V., "Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2", Nat Med., 3, pp.1285~1289 (1997)
38. Takatsuna H., "Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1", J Bone Miner Res., 20, pp.653~662 (2005)
39. Koga T., "NFAT and Osterix cooperatively regulate bone formation", Nat Med., 11, pp.880~885 (2005)
40. Lee J., "Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation", Blood., 107, pp.2686~2693 (2006)
41. Kim K., "MafB negatively regulates RANKL-mediated osteoclast differentiation", Blood., 109, pp.3253~3259 (2007)
42. Kim JH., "Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts", Cell Death Differ., 21, pp.1613~1621 (2014)
43. Kim K., "Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor", J Immunol., 178, pp.5588~5594 (2007)
44. Zhao B., "Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis", Nat Med., 15, pp.1066~1071 (2009)
45. Miyauchi Y., "The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis", J Exp Med., 207, pp.751~762 (2010)
46. Bird A., "Perceptions of epigenetics", Nature., 447, pp.396~398 (2007)
47. Yasui T., "Epigenetic regulation of osteoclast differentiation", Ann N Y Acad Sci., 1240, pp.7~13 (2011)
48. Jaenisch R., "Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals", Nat Genet., 33(Suppl), pp.245~254 (2003)
49. Yasui T., "Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1", J Bone Miner Res., 26, pp.2665~2671 (2011)
50. Bae SC, "Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation", Gene, 366, pp.58~66 (2006)
51. Kim JH., "Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1", J Biol Chem., 285, pp.5224~5231 (2010)
52. Kim JH., "RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation", Biochem J., 436, pp.253~262 (2011)
53. Ambros V., "The functions of animal microRNAs", Nature., 431, pp.350~355 (2004)
54. Bartel DP., "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell., 116, pp.281~297 (2004)
55. Chen K., "The evolution of gene regulation by transcription factors and microRNAs", Nat Rev Genet., 8, pp.93~103 (2007)
56. Kapinas K., "MicroRNA biogenesis and regulation of bone remodeling", Arthritis Res Ther., 13, pp.220~ (2011)
57. Lee Y., "MicroRNA-124 regulates osteoclast differentiation", Bone., 56, pp.383~389 (2013)
58. Mao D., "PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2", J Clin Invest., 116, pp.2869~2879 (2006)
59. Beals CR., "Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3", Science., 275, pp.1930~1934 (1997)
60. Chow CW., "Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway", Science., 278, pp.1638~1641 (1997)
61. Okamura H., "A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1", Mol Cell Biol., 24, pp.4184~4195 (2004)
62. Gómez del Arco P., "A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp", J Biol Chem., 275, pp.13872~13878 (2000)
63. Zhu J., "Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1", Cell., 93, pp.851~861 (1998)
64. Jang HD., "Inactivation of glycogen synthase kinase-3beta is required for osteoclast differentiation", J Biol Chem., 286, pp.39043~39050 (2011)
65. Koga T., "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis", Nature., 428, pp.758~763 (2004)
66. Kaifu T., "Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice", J Clin Invest., 111, pp.323~332 (2003)
67. Mócsai A., "The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase", Proc Natl Acad Sci U S A., 101, pp.6158~6163 (2004)

관련 논문AI추천